The Bundibugyo virus driving the current Ebola outbreak has no approved vaccine, but researchers are leveraging decades of vaccine innovation in an effort to change that.

An arthritis drug reduces the amount of RSV in human respiratory cells, but experts say it's too early to say if it will actually treat the common infection.

Researchers want stricter testing, better labels and accurate dosages for a wildly popular sleep aid that comes with some risks.